These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19513621)
1. Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients. Wang L; Wang X; Nie X; Ma L J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):354-8. PubMed ID: 19513621 [TBL] [Abstract][Full Text] [Related]
2. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients. Kuo SJ; Wang BB; Chang CS; Chen TH; Yeh KT; Lee DJ; Yin PL; Chen M Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Her-2/neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/neu immunostaining. Mostafa NA; Eissa SS; Belal DM; Shoman SH J Egypt Natl Canc Inst; 2011 Mar; 23(1):41-6. PubMed ID: 22099935 [TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer. Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for Her-2 status in breast cancer and its relationship to clinicopathological characteristics]. Li HH; Ma F; Zeng X; Wang JY; Yuan P; Fan Y; Xu BH Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):76-80. PubMed ID: 21418986 [TBL] [Abstract][Full Text] [Related]
6. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma. Bhargava R; Lal P; Chen B Diagn Mol Pathol; 2004 Dec; 13(4):213-6. PubMed ID: 15538111 [TBL] [Abstract][Full Text] [Related]
8. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens]. Zhang Z; Zhao L; Guo H; Guo L; Ling Y; Xu X; Zhao H; Pan Q Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):183-7. PubMed ID: 24785277 [TBL] [Abstract][Full Text] [Related]
9. [Detection of human epidermal growth factor receptor 2 gene in invasive breast cancer by fluorescence in situ hybridization and research of its association with tumor characteristics]. Su J; Yang Y; Ma XL; You JF; DU J; Liu JY; Zheng J Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):199-203. PubMed ID: 21503112 [TBL] [Abstract][Full Text] [Related]
10. HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer. Harbeck N; Ross JS; Yurdseven S; Dettmar P; Pölcher M; Kuhn W; Ulm K; Graeff H; Schmitt M Int J Oncol; 1999 Apr; 14(4):663-71. PubMed ID: 10087312 [TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features. Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240 [TBL] [Abstract][Full Text] [Related]
12. HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases. Zhang H; Ren G; Wang X; Zhao J; Yao H; Bai Y; Bo W Breast Cancer Res Treat; 2012 Jul; 134(2):743-9. PubMed ID: 22678158 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay. Goud KI; Dayakar S; Vijayalaxmi K; Babu SJ; Reddy PV Indian J Med Res; 2012 Mar; 135(3):312-7. PubMed ID: 22561616 [TBL] [Abstract][Full Text] [Related]
14. HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Moelans CB; de Weger RA; van Blokland MT; Ezendam C; Elshof S; Tilanus MG; van Diest PJ Cell Oncol; 2009; 31(1):1-10. PubMed ID: 19096145 [TBL] [Abstract][Full Text] [Related]
15. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. Pauletti G; Dandekar S; Rong H; Ramos L; Peng H; Seshadri R; Slamon DJ J Clin Oncol; 2000 Nov; 18(21):3651-64. PubMed ID: 11054438 [TBL] [Abstract][Full Text] [Related]
16. Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization. Hammock L; Lewis M; Phillips C; Cohen C Hum Pathol; 2003 Oct; 34(10):1043-7. PubMed ID: 14608539 [TBL] [Abstract][Full Text] [Related]
17. Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer. Lateef F; Jamal S; Nasir S J Coll Physicians Surg Pak; 2018 Aug; 28(8):581-585. PubMed ID: 30060783 [TBL] [Abstract][Full Text] [Related]
18. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? Sauer T; Wiedswang G; Boudjema G; Christensen H; Karesen R APMIS; 2003 Mar; 111(3):444-50. PubMed ID: 12752225 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immunohistochemistry with fluorescence in situ hybridization in determining the human epidermal growth factor receptor 2 status of breast cancer specimens: a multicenter study of 3,149 Chinese patients. Han X; Shi Y; Ma L; Lyu Z; Yang H; Yao J; Li J; Li B; Qin Y Chin Med J (Engl); 2014; 127(2):246-53. PubMed ID: 24438611 [TBL] [Abstract][Full Text] [Related]
20. HER-2 protein overexpressing breast cancer without gene amplification shows higher hormone receptor expression than HER-2 protein overexpressing breast cancer with gene amplification. Koo JS; Jung W; Yang WI Int J Surg Pathol; 2011 Aug; 19(4):425-32. PubMed ID: 19666946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]